NCT06945302View on ClinicalTrials.gov

The Effect of Inulin Supplementation in Individuals With IBS-C

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

January 3, 2022

Study Completion Date

April 1, 2023

Conditions
InulinIBS (Irritable Bowel Syndrome)Nutritional StatusAnthropometric Measurement
Interventions
DIETARY_SUPPLEMENT

Intervention Group

products containing a total of 9.2 g (4.6 g twice a day) inulin/oligofructose (50/50) mixture (prebiotic group) that individuals should consume daily were delivered to individuals in identical opaque bags.

DIETARY_SUPPLEMENT

Control group (placebo)

products containing a total of 9.2 g (4.6 g twice a day) maltodextrin (placebo group) that individuals should consume daily were delivered to individuals in identical opaque bags.

Trial Locations (1)

47200

Mardin Artuklu University, Mardin

All Listed Sponsors
lead

Mardin Artuklu University

OTHER

NCT06945302 - The Effect of Inulin Supplementation in Individuals With IBS-C | Biotech Hunter | Biotech Hunter